1 |
TELLUM T, NYGAARD S, SKOVHOLT E K,et al. Development of a clinical prediction model for diagnosing adenomyosis[J]. Fertil Steril, 2018,110(5):957-964.e3.
|
2 |
冷金花. 子宫腺肌病诊治中国专家共识[J]. 中华妇产科杂志, 2020, 55(6): 376-383.
|
3 |
中国医师协会妇产科医师分会子宫内膜异位症专业委员会.子宫腺肌病诊治中国专家共识[J].中华妇产科杂志, 2020, 55(6): 376-383.
|
4 |
LIU L, LUO N, GUO J, et al. Berberine inhibits growth and inflammatory invasive phenotypes of ectopic stromal cells: imply the possible treatment of adenomyosis[J]. J Pharmacol Sci, 2018, 137(1): 5-11.
|
5 |
DUEHOLM M. Uterine adenomyosis and infertility, review of reproductive outcome after invitro fertilization and surgery[J].Acta Obstet Gynecol Scand,2017,96(6): 715-726.
|
6 |
石路莹, 段静雅, 张继花, 等. COX-2、SFRP4和WBP2在子宫腺肌病病灶中的表达及与临床特征的关系[J]. 中国医学创新, 2022, 19(13): 1-7.
|
7 |
李灿宇, 刘欢欢, 王婷婷, 等. COX-2、MMP-9和VEGF在子宫腺肌病异位内膜间质细胞中的表达及其意义[J]. 实用医学杂志, 2018, 34(23): 3869-3873.
|
8 |
凌 静, 甄玉花, 张明子, 等. Wnt/β-catenin通路调控子宫内膜异位症、子宫腺肌病上皮间质转化和中药干预策略及机制[J]. 现代中西医结合杂志, 2022, 31(15): 2181-2186.
|
9 |
OH S J, SHIN J H, KIM T H, et al. β-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition[J]. J Pathol, 2013, 231(2): 210-222.
|
10 |
LI C X, CHEN R, JIANG C X, et al. Correlation of LOX‑5 and COX‑2 expression with inflammatory pathology and clinical features of adenomyosis[J]. Mol Med Rep, 2019, 19(1): 727-733.
|
11 |
胡再孟. 子宫腺肌症的病理生理机制和诊断学研究进展[J]. 医学研究杂志, 2014, 43(3): 15-18.
|
12 |
乌音嘎, 郑 健. 膜联蛋白A2在子宫腺肌病中的表达及其与痛经的关系[J]. 实用医学杂志, 2016, 32(22): 3702-3705.
|
13 |
LEYENDECKER G, WILDT L. A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR)[J]. Horm Mol Biol Clin Investig, 2011, 5(2): 125-142.
|
14 |
POLYAK K, WEINBERG R A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits[J]. Nat Rev Cancer, 2009, 9(4): 265-273.
|
15 |
黎 霓, 王国云. 子宫腺肌病发病机制的研究现状[J]. 中国实用妇科与产科杂志, 2019, 35(5): 493-498.
|
16 |
AN M, LI D, YUAN M, et al. Different macrophages equally induce EMT in endometria of adenomyosis and normal[J]. Reproduction, 2017, 154(1): 79-92.
|
17 |
WANG F, SHI X X, QIN X Y, et al. Expression of CD56 in patients with adenomyosis and its correlation with dysmenorrhea[J]. Eur J Obstet Gynecol Reprod Biol, 2015, 194: 101-105.
|
18 |
WANG Y Y, DUAN H, WANG S, et al. Talin1 induces epithelial-mesenchymal transition to facilitate endometrial cell migration and invasion in adenomyosis under the regulation of microRNA-145-5p[J]. Reprod Sci, 2021, 28(5): 1523-1539.
|
19 |
YOO J Y, KU B J, KIM T H, et al. β-catenin activates TGF-β-induced epithelial-mesenchymal transition in adenomyosis[J]. Exp Mol Med, 2020, 52(10): 1754-1765.
|
20 |
LIU Y Q, WANG X Y, WAN L, et al. TIPE2 inhibits the migration and invasion of endometrial cells by targeting β-catenin to reverse epithelial-mesenchymal transition[J]. Hum Reprod, 2020, 35(6): 1377-1390.
|
21 |
黄先华, 刘 婷, 王 青. 子宫腺肌病患者内膜组织淋巴增强结合因子1、β-连环素表达及临床意义[J]. 中国计划生育学杂志, 2021, 29(7): 1444-1448.
|
22 |
SHEN J, LI W X, XIAO Z G, et al. The co-regulatory role of 5-lipoxygenase and cyclooxygenase-2 in the carcinogenesis and their promotion by cigarette smoking in colons[J]. Curr Med Chem, 2016, 23(11): 1131-1138.
|
23 |
LEONE ROBERTI MAGGIORE U, FERRERO S. Methodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of women with endometriosis[J]. Int J Fertil Steril, 2015, 8(4): 485-486.
|
24 |
CAVALCANTI V, PONCE T G, MAFRA F A,et al. Evaluation of the frequency of G-765C polymorphism in the promoter region of the COX-2 gene and its correlation with the expression of this gene in the endometrium of women with endometriosis[J]. Arch Gynecol Obstet, 2016, 293(1): 109-115.
|
25 |
HAN Y, GUO W, REN T T, et al. Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis[J]. Cancer Lett, 2019, 440/441: 116-125.
|
26 |
QIN G, XU F, QIN T, et al. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway[J]. Oncotarget, 2015, 6(39): 41794-41808.
|
27 |
GUO S W. The pathogenesis of adenomyosis vis-à-vis endometriosis[J]. J Clin Med, 2020, 9(2): 485.
|
28 |
JIN Z X, WU X Y, LIU H O,et al.Celecoxib,a selective COX-2 inhibitor, markedly reduced the severity of tamoxifen-induced adenomyosis in a murine model[J]. Exp Ther Med, 2020, 19(5): 3289-3299.
|
29 |
LIU L X, WU Y G, ZHENG J. Increased annexin A2 and decreased β-catenin in adenomyosis contribute to adenomyosis-associated dysmenorrhea[J]. Histol Histopathol, 2017, 32(12): 1333-1340.
|